Evaluation of 18F-FDG PET/CT and CT/MRI with histopathologic correlation in patients undergoing salvage surgery for head and neck squamous cell carcinoma

Annals of Surgical Oncology

Volumn 18, Issue 9, 2011, Pages 2579-2584

  Kim, Sang Yoon ^a   Kim, Jae Seung ^a   Yi, Jong Sook ^a   Lee, Jeong Hyun ^a   Choi, Seung Ho ^a   Nam, Soon Yuhl ^a   Cho, Kyung Ja ^a   Lee, Sang Wook ^a   Kim, Sung Bae ^a   Roh, Jong Lyel ^a  

^a University of Ulsan   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; CISPLATIN; DOCETAXEL; FLUORODEOXYGLUCOSE F 18; FLUOROURACIL; TS 1; UNCLASSIFIED DRUG; DIAGNOSTIC AGENT; RADIOPHARMACEUTICAL AGENT;

ADULT; AGED; ARTICLE; CANCER COMBINATION CHEMOTHERAPY; CANCER RADIOTHERAPY; CHEMORADIOTHERAPY; CLINICAL ARTICLE; COMPUTER ASSISTED EMISSION TOMOGRAPHY; COMPUTER ASSISTED TOMOGRAPHY; CONTINUOUS INFUSION; CORRELATION ANALYSIS; DIAGNOSTIC VALUE; FEMALE; HEAD AND NECK CARCINOMA; HISTOPATHOLOGY; HUMAN; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; SALVAGE THERAPY; SQUAMOUS CELL CARCINOMA; TREATMENT OUTCOME; FOLLOW UP; HEAD AND NECK TUMOR; LYMPH NODE METASTASIS; MIDDLE AGED; MINIMAL RESIDUAL DISEASE; PATHOLOGY; POSITRON EMISSION TOMOGRAPHY; PROGNOSIS;

ADULT; AGED; CARCINOMA, SQUAMOUS CELL; CHEMORADIOTHERAPY; FEMALE; FLUORODEOXYGLUCOSE F18; FOLLOW-UP STUDIES; HEAD AND NECK NEOPLASMS; HUMANS; LYMPHATIC METASTASIS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; NEOPLASM, RESIDUAL; POSITRON-EMISSION TOMOGRAPHY; PROGNOSIS; RADIOPHARMACEUTICALS; SALVAGE THERAPY; TOMOGRAPHY, X-RAY COMPUTED;

EID: 80052705874     PISSN: 10689265     EISSN: 15344681     Source Type: Journal    
DOI: 10.1245/s10434-011-1655-x     Document Type: Article

References (24)

1. N Choong E Vokes 2008 Expanding role of the medical oncologist in the management of head and neck cancer CA Cancer J Clin. 58 32 53 18096865 10.3322/CA.2007.0004
2. A Langerman C Plein EE Vokes, et al. 2009 Neck response to chemoradiotherapy: complete radiographic response correlates with pathologic complete response in locoregionally advanced head and neck cancer Arch Otolaryngol Head Neck Surg. 135 1133 1136 19917927 10.1001/archoto.2009.154
3. J Bussink CM van Herpen JH Kaanders WJ Oyen 2010 PET-CT for response assessment and treatment adaptation in head and neck cancer Lancet Oncol. 11 661 669 20226735 10.1016/S1470-2045(09)70353-5
4. RA Velázquez HS McGuff D Sycamore FR Miller 2004 The role of computed tomographic scans in the management of the N-positive neck in head and neck squamous cell carcinoma after chemoradiotherapy Arch Otolaryngol Head Neck Surg. 130 74 77 14732772 10.1001/archotol.130.1.74 (Pubitemid 38095433)
5. A Tan DJ Adelstein LA Rybicki, et al. 2007 Ability of positron emission tomography to detect residual neck node disease in patients with head and neck squamous cell carcinoma after definitive chemoradiotherapy Arch Otolaryngol Head Neck Surg. 133 435 440 17515501 10.1001/archotol.133.5.435 (Pubitemid 46799778)
6. H Inohara K Enomoto Y Tomiyama, et al. 2009 The role of CT and (18)F-FDG PET in managing the neck in node-positive head and neck cancer after chemoradiotherapy Acta Otolaryngol. 129 893 899 18839385 10.1080/ 00016480802441747
7. VA Passero BF Branstetter Y Shuai, et al. 2010 Response assessment by combined PET-CT scan versus CT scan alone using RECIST in patients with locally advanced head and neck cancer treated with chemoradiotherapy Ann Oncol. 21 2278 2283 20430907 10.1093/annonc/mdq226 1:STN:280:DC%2BC3cbhtl2qsA%3D%3D
8. 18F-FDG PET/CT in assessing the neck after concurrent chemoradiotherapy for locoregional advanced head and neck cancer J Nucl Med. 49 532 540 18344440 10.2967/jnumed.107.044792 (Pubitemid 351520600)
9. M Yao RB Smith HT Hoffman, et al. 2009 Clinical significance of postradiotherapy [18F]-fluorodeoxyglucose positron emission tomography imaging in management of head-and-neck cancer-a long-term outcome report Int J Radiat Oncol Biol Phys. 74 9 14 18930358 10.1016/j.ijrobp.2008.07.019 1:CAS:528:DC%2BD1MXktl2jsb4%3D
10. SV Porceddu E Jarmolowski RJ Hicks, et al. 2005 Utility of positron emission tomography for the detection of disease in residual neck nodes after (chemo)radiotherapy in head and neck cancer Head Neck. 27 175 181 15627258 10.1002/hed.20130 (Pubitemid 40315765)
11. KT Robbins G Clayman PA Levine, et al. 2002 Neck dissection classification update: revisions proposed by the American Head and Neck Society and the American Academy of Otolaryngology-Head and Neck Surgery Arch Otolaryngol Head Neck Surg. 128 751 758 12117328 (Pubitemid 34755299)
12. PM Som HD Curtin AA Mancuso 2000 Imaging-based nodal classification for evaluation of neck metastatic adenopathy Am J Roentgenol. 174 837 844 1:STN:280:DC%2BD3c7mtlGksw%3D%3D (Pubitemid 30126275)
13. 18F-FDG PET with conventional imaging modalities (MRI, CT, and 67 Ga scintigraphy) in assessment of combined intraarterial chemotherapy and radiotherapy for head and neck carcinoma J Nucl Med. 44 198 206 12571209
14. KM Greven DW Williams 3rd WF McGuirt Sr, et al. 2001 Serial positron emission tomography scans following radiation therapy of patients with head and neck cancer Head Neck. 23 942 946 11754497 10.1002/hed.1136 1:STN:280: DC%2BD38%2FgtVamuw%3D%3D (Pubitemid 32977536)
15. MG Isles C McConkey HM Mehanna 2008 A systematic review and meta-analysis of the role of positron emission tomography in the follow up of head and neck squamous cell carcinoma following radiotherapy or chemoradiotherapy Clin Otolaryngol. 33 210 222 18559026 10.1111/j.1749-4486.2008.01688.x 1:STN:280:DC%2BD1czpt1Citw%3D%3D (Pubitemid 351799005)
16. RS Andrade DE Heron B Degirmenci, et al. 2006 Posttreatment assessment of response using FDG-PET/CT for patients treated with definitive radiation therapy for head and neck cancers Int J Radiat Oncol Biol Phys. 65 1315 1322 16750327 10.1016/j.ijrobp.2006.03.015 (Pubitemid 44425218)
17. MB Fukui TM Blodgett CH Snyderman, et al. 2005 Combined PET-CT in the head and neck: part 2. Diagnostic uses and pitfalls of oncologic imaging Radiographics. 25 913 930 16009815 10.1148/rg.254045136 (Pubitemid 41196929)
18. CG Gourin BJ Boyce HT Williams AV Herdman PA Bilodeau TA Coleman 2009 Revisiting the role of positron-emission tomography/computed tomography in determining the need for planned neck dissection following chemoradiation for advanced head and neck cancer Laryngoscope. 119 2150 2155 19544378 10.1002/lary.20523
19. 18F-fluorodeoxyglucose in the initial staging of nodal negative oral and oropharyngeal squamous cell carcinoma Head Neck. 24 345 349 11933176 10.1002/hed.10057 (Pubitemid 34260038)
20. 18F-FDG PET and CT/MRI in oral cavity squamous cell carcinoma: a prospective study of 124 patients with histologic correlation J Nucl Med. 46 1136 1143 16000282
21. Y Yamazaki M Saitoh K Notani, et al. 2008 Assessment of cervical lymph node metastases using FDG-PET in patients with head and neck cancer Ann Nucl Med. 22 177 184 18498032 10.1007/s12149-007-0097-9 (Pubitemid 351729627)
22. JL Roh NK Yeo JS Kim, et al. 2007 Utility of 2-[18F] fluoro-2-deoxy-D- glucose positron emission tomography and positron emission tomography/computed tomography imaging in the preoperative staging of head and neck squamous cell carcinoma Oral Oncol. 43 887 893 17207656 10.1016/j.oraloncology.2006.10.011 (Pubitemid 47369251)
23. M Yao RB Smith MM Graham, et al. 2005 The role of FDG PET in management of neck metastasis from head-and-neck cancer after definitive radiation treatment Int J Radiat Oncol Biol Phys. 63 991 999 16099601 10.1016/j.ijrobp. 2005.03.066 (Pubitemid 41505274)
24. LJ Peters RS Weber WH Morrison RM Byers AS Garden H Goepfert 1996 Neck surgery in patients with primary oropharyngeal cancer treated by radiotherapy Head Neck. 18 552 559 8902569 10.1002/(SICI)1097-0347(199611/12)18:6<552:: AID-HED10>3.0.CO;2-A 1:STN:280:DyaK2s%2FlvVansg%3D%3D (Pubitemid 26349535)